Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001729197-18-000003)

Filing Details

Accession Number:: 0001729197-18-000003
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2018-12-11 17:22:21
Reporting Period:: 2018-12-10

Accepted Time:: 2018-12-11 17:22:21
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1534120	Cerecor Inc.	CERC	Pharmaceutical Preparations (2834)	450705648

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1729197	V Matthew Phillips	C/O Cerecor Inc. 400 E. Pratt Street, Suite 606 Baltimore MD 21202	Chief Commercial Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2018-12-10	497	$2.85	497	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Reported Derivative Holdings

Show Other Fields >>

Sec. Name	Sec. Type	Price	Date	Expiration Date	Amount	Remaning Holdings	Nature of Ownership
Common Stock	Stock Option (right to buy)	$1.13		2027-11-17	100,000	100,000	Direct
Common Stock	Stock Option (right to buy)	$3.21		2028-01-22	100,000	100,000	Direct

Expiration Date	Amount	Remaning Holdings	Nature of Ownership
2027-11-17	100,000	100,000	Direct
2028-01-22	100,000	100,000	Direct

Footnotes

These shares were acquired under the Issuer's 2016 Employee Stock Purchase Plan.
The grant shall vest one-fourth on each of the first, second, third and fourth anniversaries of the date of grant, provided Mr. Phillips is then an officer of the Company.